⌘K

Login Start Free

Home/Filings/4/0001127602-25-015264

4//SEC Filing

De Witte Jan 4

Accession 0001127602-25-015264

CIK 0000943819other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 10:05 AM ET

Size

4.4 KB

Accession

0001127602-25-015264

Insider Transaction Report

Form 4

Period: 2025-05-20

Director

Transactions

Sale
ReMed Common Stock
2025-05-20$243.47/sh−2,000$486,940→ 5,806 total

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 3, 2025.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001776929

Filing Metadata

Form type: 4
Filed: May 21, 8:00 PM ET
Accepted: May 22, 10:05 AM ET
Size: 4.4 KB

View on SEC.gov